Oxidized LDL but not total LDL is associated with HbA1c in individuals without diabetes

Débora Spessatto1, Liz Marina Bueno Dos Passos Brum2, Joíza Lins Camargo3

  • 1Graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.

Insights

Glycated hemoglobin (HbA1c) is linked to oxidized LDL (oxi-LDL) in non-diabetics. Higher oxi-LDL indicates increased risk for diabetes and cardiovascular disease, suggesting HbA1c can identify at-risk individuals.

Area of Science:

  • Cardiovascular Health
  • Metabolic Syndrome Research
  • Biomarker Discovery

Background:

  • Glycated hemoglobin (HbA1c) reflects average blood glucose over time.
  • Oxidized low-density lipoprotein (oxi-LDL) is implicated in atherosclerosis.
  • Understanding their relationship in non-diabetic individuals is crucial for early risk assessment.

Purpose of the Study:

  • To investigate the association between HbA1c, LDL, and oxi-LDL in individuals without diabetes.
  • To determine if HbA1c can serve as a biomarker for identifying individuals at risk of developing complications.

Main Methods:

  • 196 non-diabetic individuals were enrolled and categorized into three groups based on HbA1c and fasting plasma glucose.
  • Measurements included HbA1c, oxi-LDL, LDL, and lipid profiles.
  • Multiple linear regression analysis was used to adjust for confounding variables.

Main Results:

  • Significant differences in oxi-LDL levels were observed across all groups, with the highest in group 3 (p<0.001).
  • HbA1c showed moderate positive associations with oxi-LDL, oxi-LDL/HDL, and oxi-LDL/LDL ratios (p<0.001).
  • Traditional atherogenic lipids like LDL and triglycerides showed only weak associations with HbA1c.

Conclusions:

  • Oxi-LDL levels are significantly associated with HbA1c in non-diabetic individuals.
  • Elevated oxi-LDL is linked to higher risk for diabetes and cardiovascular disease.
  • HbA1c may be a valuable biomarker for identifying at-risk individuals even with non-diabetic glycemic levels.
Abstract

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.6K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K